Krilac,I’d be interested in your take on the “Complete Vaccine “ … given the timeframes for trials and approval and the trajectory for the pandemic … Is it even relevant in any SP estimate? The NGIO valuation is pre COVID. I think any potential for the “Complete Vaccine “ depends on if the booster efficacy wanes over time …
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links